Freenome, Inc. (FRNM): Total Assets
$92.78M
As of 2025-12-31
$85.83M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $92.78M | +3.2% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $89.90M | n/a | 2026-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Freenome, Inc. (FRNM) | 2025-12-31 | $92.78M | +3.2% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $101.93M | +40.5% |
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $38.06M | +285.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Celcuity Inc. (CELC) | 2025-12-31 | $466.56M | +90.3% |
Compare FRNM, BDSX, SERA, XGN side by side · Screen every company in Services-Medical Laboratories ↗